• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人骨髓间充质干细胞的细胞起源决定了其在心脏再生中的不同修复性能。

Cell origin of human mesenchymal stem cells determines a different healing performance in cardiac regeneration.

机构信息

Reference and Translation Center for Cardiac Stem Cell Therapy (RTC), Department of Cardiac Surgery, University of Rostock, Rostock, Germany.

出版信息

PLoS One. 2011 Feb 10;6(2):e15652. doi: 10.1371/journal.pone.0015652.

DOI:10.1371/journal.pone.0015652
PMID:21347366
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3037376/
Abstract

The possible different therapeutic efficacy of human mesenchymal stem cells (hMSC) derived from umbilical cord blood (CB), adipose tissue (AT) or bone marrow (BM) for the treatment of myocardial infarction (MI) remains unexplored. This study was to assess the regenerative potential of hMSC from different origins and to evaluate the role of CD105 in cardiac regeneration. Male SCID mice underwent LAD-ligation and received the respective cell type (400.000/per animal) intramyocardially. Six weeks post infarction, cardiac catheterization showed significant preservation of left ventricular functions in BM and CD105(+)-CB treated groups compared to CB and nontreated MI group (MI-C). Cell survival analyzed by quantitative real time PCR for human GAPDH and capillary density measured by immunostaining showed consistent results. Furthermore, cardiac remodeling can be significantly attenuated by BM-hMSC compared to MI-C. Under hypoxic conditions in vitro, remarkably increased extracellular acidification and apoptosis has been detected from CB-hMSC compared to BM and CD105 purified CB-derived hMSC. Our findings suggests that hMSC originating from different sources showed a different healing performance in cardiac regeneration and CD105(+) hMSC exhibited a favorable survival pattern in infarcted hearts, which translates into a more robust preservation of cardiac function.

摘要

尚未探索源自脐血(CB)、脂肪组织(AT)或骨髓(BM)的人骨髓间充质干细胞(hMSC)在治疗心肌梗死(MI)方面可能存在不同的治疗效果。本研究旨在评估不同来源的 hMSC 的再生潜力,并评估 CD105 在心脏再生中的作用。雄性 SCID 小鼠接受 LAD 结扎,并接受相应的细胞类型(每只动物 400,000 个)心肌内注射。心肌梗死 6 周后,心脏导管检查显示与 CB 和未治疗的 MI 组(MI-C)相比,BM 和 CD105(+)CB 处理组的左心室功能明显得到保存。通过定量实时 PCR 分析人类 GAPDH 和免疫染色测量的毛细血管密度来评估细胞存活,结果一致。此外,与 MI-C 相比,BM-hMSC 可显著减轻心脏重塑。在体外缺氧条件下,与 BM 和 CD105 纯化 CB 来源的 hMSC 相比,从 CB-hMSC 中检测到明显增加的细胞外酸化和细胞凋亡。我们的研究结果表明,源自不同来源的 hMSC 在心脏再生中表现出不同的愈合性能,CD105(+)hMSC 在梗死心脏中表现出有利的存活模式,从而更有效地保存心脏功能。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1d1/3037376/4581cf64a7e8/pone.0015652.g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1d1/3037376/33d430852416/pone.0015652.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1d1/3037376/46b1c52c3fd6/pone.0015652.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1d1/3037376/23a24d8c2cfe/pone.0015652.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1d1/3037376/add40a1317e1/pone.0015652.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1d1/3037376/7f1162669f85/pone.0015652.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1d1/3037376/0b3881f4b39c/pone.0015652.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1d1/3037376/a025d45986d8/pone.0015652.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1d1/3037376/a39ef3d47b8e/pone.0015652.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1d1/3037376/4581cf64a7e8/pone.0015652.g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1d1/3037376/33d430852416/pone.0015652.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1d1/3037376/46b1c52c3fd6/pone.0015652.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1d1/3037376/23a24d8c2cfe/pone.0015652.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1d1/3037376/add40a1317e1/pone.0015652.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1d1/3037376/7f1162669f85/pone.0015652.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1d1/3037376/0b3881f4b39c/pone.0015652.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1d1/3037376/a025d45986d8/pone.0015652.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1d1/3037376/a39ef3d47b8e/pone.0015652.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1d1/3037376/4581cf64a7e8/pone.0015652.g009.jpg

相似文献

1
Cell origin of human mesenchymal stem cells determines a different healing performance in cardiac regeneration.人骨髓间充质干细胞的细胞起源决定了其在心脏再生中的不同修复性能。
PLoS One. 2011 Feb 10;6(2):e15652. doi: 10.1371/journal.pone.0015652.
2
Patterning human stem cells and endothelial cells with laser printing for cardiac regeneration.激光打印对人心肌干细胞和内皮细胞进行图案化处理以促进心脏再生。
Biomaterials. 2011 Dec;32(35):9218-30. doi: 10.1016/j.biomaterials.2011.08.071. Epub 2011 Sep 10.
3
Genetic modification of mesenchymal stem cells overexpressing CCR1 increases cell viability, migration, engraftment, and capillary density in the injured myocardium.过表达 CCR1 的间充质干细胞的基因修饰可增加损伤心肌中的细胞活力、迁移、植入和毛细血管密度。
Circ Res. 2010 Jun 11;106(11):1753-62. doi: 10.1161/CIRCRESAHA.109.196030. Epub 2010 Apr 8.
4
Chitosan/silk fibroin modified nanofibrous patches with mesenchymal stem cells prevent heart remodeling post-myocardial infarction in rats.壳聚糖/丝素蛋白改性纳米纤维贴片联合间充质干细胞预防大鼠心肌梗死后心脏重构。
Acta Biomater. 2018 Oct 15;80:154-168. doi: 10.1016/j.actbio.2018.09.013. Epub 2018 Sep 13.
5
Intramyocardial angiogenetic stem cells and epicardial erythropoietin save the acute ischemic heart.心肌内血管生成干细胞和心外膜促红细胞生成素拯救急性缺血性心脏。
Dis Model Mech. 2018 Jun 22;11(6):dmm033282. doi: 10.1242/dmm.033282.
6
Bone-derived Nestin-positive mesenchymal stem cells improve cardiac function via recruiting cardiac endothelial cells after myocardial infarction.骨源巢蛋白阳性间充质干细胞通过梗死心肌后募集心脏内皮细胞改善心功能。
Stem Cell Res Ther. 2019 Apr 27;10(1):127. doi: 10.1186/s13287-019-1217-x.
7
Direct comparison of different stem cell types and subpopulations reveals superior paracrine potency and myocardial repair efficacy with cardiosphere-derived cells.不同干细胞类型和亚群的直接比较显示,心球源性细胞具有更好的旁分泌效力和心肌修复效果。
J Am Coll Cardiol. 2012 Mar 6;59(10):942-53. doi: 10.1016/j.jacc.2011.11.029.
8
Angiogenic Potential of Bone Marrow Derived CD133 and CD271 Intramyocardial Stem Cell Trans- Plantation Post MI.骨髓源性 CD133 和 CD271 心肌内干细胞移植治疗 MI 的血管生成潜力。
Cells. 2019 Dec 27;9(1):78. doi: 10.3390/cells9010078.
9
Secretome from Human Mesenchymal Stem Cells-Derived Endothelial Cells Promotes Wound Healing in a Type-2 Diabetes Mouse Model.人骨髓间充质干细胞来源的内皮细胞分泌组促进 2 型糖尿病小鼠模型的伤口愈合。
Int J Mol Sci. 2022 Jan 15;23(2):941. doi: 10.3390/ijms23020941.
10
Exosomes Derived from Akt-Modified Human Umbilical Cord Mesenchymal Stem Cells Improve Cardiac Regeneration and Promote Angiogenesis via Activating Platelet-Derived Growth Factor D.Akt 修饰的人脐带间充质干细胞来源的外泌体通过激活血小板衍生生长因子 D 改善心脏再生和促进血管生成。
Stem Cells Transl Med. 2017 Jan;6(1):51-59. doi: 10.5966/sctm.2016-0038. Epub 2016 Sep 22.

引用本文的文献

1
State-of the-art and future perspective in co-culture systems for tendon engineering.用于肌腱工程的共培养系统的现状与未来展望。
Biomater Biosyst. 2025 Mar 5;17:100110. doi: 10.1016/j.bbiosy.2025.100110. eCollection 2025 Mar.
2
Salivary Gland Bioengineering.唾液腺生物工程
Bioengineering (Basel). 2023 Dec 26;11(1):28. doi: 10.3390/bioengineering11010028.
3
Progress and emerging techniques for biomaterial-based derivation of mesenchymal stem cells (MSCs) from pluripotent stem cells (PSCs).基于生物材料从多能干细胞(PSC)衍生间充质干细胞(MSC)的研究进展与新兴技术。

本文引用的文献

1
Polyethylenimine-mediated gene delivery into human bone marrow mesenchymal stem cells from patients.聚乙稀亚胺介导的基因转染入患者骨髓间充质干细胞。
J Cell Mol Med. 2011 Sep;15(9):1989-98. doi: 10.1111/j.1582-4934.2010.01130.x. Epub 2010 Jul 13.
2
Intracardiac injection of matrigel induces stem cell recruitment and improves cardiac functions in a rat myocardial infarction model.心肌内注射基质胶可诱导干细胞募集并改善大鼠心肌梗死模型的心脏功能。
J Cell Mol Med. 2011 Jun;15(6):1310-8. doi: 10.1111/j.1582-4934.2010.01086.x. Epub 2010 May 14.
3
Different facets of aging in human mesenchymal stem cells.
Biomater Res. 2023 Apr 18;27(1):31. doi: 10.1186/s40824-023-00371-0.
4
Stem cell-based therapy for human diseases.基于干细胞的人类疾病治疗方法。
Signal Transduct Target Ther. 2022 Aug 6;7(1):272. doi: 10.1038/s41392-022-01134-4.
5
Comparative analysis of dental pulp stem cells and stem cells from human exfoliated teeth in terms of growth kinetics, immunophenotype, self-renewal and multi lineage differentiation potential for future perspective of calcified tissue regeneration.牙髓干细胞与脱落乳牙干细胞在生长动力学、免疫表型、自我更新及多谱系分化潜能方面的比较分析,以展望钙化组织再生的未来前景。
Pak J Med Sci. 2022 May-Jun;38(5):1228-1237. doi: 10.12669/pjms.38.5.5187.
6
Differentiation Capacity of Human Urine-Derived Stem Cells to Retain Telomerase Activity.人尿源干细胞保留端粒酶活性的分化能力。
Front Cell Dev Biol. 2022 May 23;10:890574. doi: 10.3389/fcell.2022.890574. eCollection 2022.
7
Surfing the clinical trials of mesenchymal stem cell therapy in ischemic cardiomyopathy.搜索间充质干细胞治疗缺血性心肌病的临床试验。
Stem Cell Res Ther. 2021 Jun 23;12(1):361. doi: 10.1186/s13287-021-02443-1.
8
Consistent Long-Term Therapeutic Efficacy of Human Umbilical Cord Matrix-Derived Mesenchymal Stromal Cells After Myocardial Infarction Despite Individual Differences and Transient Engraftment.心肌梗死后人脐带基质来源间充质基质细胞的长期治疗效果一致,尽管存在个体差异和短暂植入。
Front Cell Dev Biol. 2021 Feb 4;9:624601. doi: 10.3389/fcell.2021.624601. eCollection 2021.
9
Immunophenotypic characteristics of multipotent mesenchymal stromal cells that affect the efficacy of their use in the prevention of acute graft host disease.多能间充质基质细胞的免疫表型特征影响其在预防急性移植物抗宿主病中应用的疗效。
World J Stem Cells. 2020 Nov 26;12(11):1377-1395. doi: 10.4252/wjsc.v12.i11.1377.
10
Large-Scale Expansion of Human Mesenchymal Stem Cells.人骨髓间充质干细胞的大规模扩增
Stem Cells Int. 2020 Jul 15;2020:9529465. doi: 10.1155/2020/9529465. eCollection 2020.
人类间充质干细胞衰老的不同方面。
Tissue Eng Part B Rev. 2010 Aug;16(4):445-53. doi: 10.1089/ten.TEB.2009.0825.
4
Hypoxic/normoxic preconditioning increases endothelial differentiation potential of human bone marrow CD133+ cells.低氧/常氧预处理可提高人骨髓 CD133+ 细胞的内皮细胞分化潜能。
Tissue Eng Part C Methods. 2010 Oct;16(5):1069-81. doi: 10.1089/ten.TEC.2009.0641.
5
Replicative senescence-associated gene expression changes in mesenchymal stromal cells are similar under different culture conditions.间充质基质细胞复制性衰老相关基因表达变化在不同培养条件下相似。
Haematologica. 2010 Jun;95(6):867-74. doi: 10.3324/haematol.2009.011692. Epub 2010 Jan 6.
6
Stem cell-mediated neovascularization in heart repair.干细胞介导的心脏修复中的新生血管形成。
Ther Adv Cardiovasc Dis. 2010 Feb;4(1):27-42. doi: 10.1177/1753944709353338. Epub 2009 Dec 30.
7
DNA methylation pattern changes upon long-term culture and aging of human mesenchymal stromal cells.人类间充质基质细胞长期培养和衰老时 DNA 甲基化模式发生变化。
Aging Cell. 2010 Feb;9(1):54-63. doi: 10.1111/j.1474-9726.2009.00535.x. Epub 2009 Nov 6.
8
Hsp20-engineered mesenchymal stem cells are resistant to oxidative stress via enhanced activation of Akt and increased secretion of growth factors.热休克蛋白 20 工程化间充质干细胞通过增强 Akt 的激活和增加生长因子的分泌来抵抗氧化应激。
Stem Cells. 2009 Dec;27(12):3021-31. doi: 10.1002/stem.230.
9
A transformed cell population derived from cultured mesenchymal stem cells has no functional effect after transplantation into the injured heart.源自培养的间充质干细胞的转化细胞群体移植到受损心脏后没有功能效应。
Cell Transplant. 2009;18(3):319-31. doi: 10.3727/096368909788534906.
10
Aging and replicative senescence have related effects on human stem and progenitor cells.衰老和复制性衰老对人类干细胞和祖细胞有相关影响。
PLoS One. 2009 Jun 9;4(6):e5846. doi: 10.1371/journal.pone.0005846.